Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |